Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-043962

Chief Financial Officer sold 752 shares at $15.67 ($11,784)

  • Chief Financial Officer acquired 2,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-30 Exercise or conversion : show line 1 in the form +2,886 73,408 D
2022-08-01 Sale : show line 2 in the form −752 $15.67 $11,784 72,656 D
Open-market sales · 752 sh · avg $15.67 · $11,784

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,886 40,405 D
Loading xslF345X03/doc4.xml…